Adverum Biotechnologies/ US00773U1088 /

12/6/2023 6:59:31 PM	Chg. 0.00	Volume	Bid7:12:26 PM	Ask7:12:26 PM	High	Low
0.89USD	+0.14%	1,562 Turnover: 1,367.58	0.81Bid Size: 100	0.97Ask Size: 100	0.89	0.87

GlobeNewswire 3/29/2022 Nkarta Appoints Manufacturing Technology Executive, Angela Thedinga, to Board of Directors

GlobeNewswire 3/17/2022 Adverum Appoints Rabia Gurses Ozden, M.D. and Soo J. Hong, M.B.A., to Board of Directors

GlobeNewswire 2/28/2022 Adverum Biotechnologies to Participate in the 42nd Annual Cowen Healthcare Conference

GlobeNewswire 2/7/2022 Adverum Biotechnologies Appoints Richard Beckman M.D. as Chief Medical Officer

GlobeNewswire 1/6/2022 Adverum Biotechnologies Appoints Star Seyedkazemi, Pharm.D. as Chief Development Officer

GlobeNewswire 1/4/2022 Adverum Biotechnologies Granted Orphan Drug Designation by FDA for Gene Therapy Candidate in Preclin...

GlobeNewswire 12/21/2021 Adverum Biotechnologies Provides ADVM-022 Development Update and Anticipated Corporate Milestones fo...

GlobeNewswire 12/9/2021 SparingVision Strengthens Leadership Team with the Appointment of Dr Mehdi Gasmi as Chief Operating ...

GlobeNewswire 12/6/2021 Adverum Biotechnologies Appoints Rupert D’Souza, Ph.D., M.B.A. as Chief Financial Officer

GlobeNewswire 11/4/2021 Adverum Reports Third Quarter 2021 Results

GlobeNewswire 10/9/2021 Adverum Presents Clinical Data on ADVM-022 at the American Society of Retina Specialists 39th Annual...

GlobeNewswire 10/1/2021 Adverum Presents 2-Year OPTIC Data Demonstrating Sustained Durability and Promising Safety Profile f...

GlobeNewswire 9/27/2021 Adverum to Present Data from ADVM-022 Clinical Trials at Upcoming Medical Conferences

GlobeNewswire 9/9/2021 Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation ...

GlobeNewswire 8/23/2021 Adverum Appoints Global Regulatory Leader Jim Wang, Ph.D., as Senior Vice President, Head of Regulat...

GlobeNewswire 8/5/2021 Adverum Reports Second Quarter 2021 Results

GlobeNewswire 7/22/2021 Adverum Provides Update on ADVM-022 and the INFINITY Trial in Patients with Diabetic Macular Edema

GlobeNewswire 7/1/2021 Adverum Announces Appointment of Jon Williams, Ph.D., as Vice President, Clinical Affairs

GlobeNewswire 6/24/2021 Adverum Announces Changes to Management Team

GlobeNewswire 6/1/2021 Adverum Appoints CMO and CSO

GlobeNewswire 5/12/2021 Adverum Stockholders Re-Elect All Adverum Director Nominees at 2021 Annual Meeting

GlobeNewswire 5/10/2021 Adverum Issues Statement Regarding Upcoming Annual Meeting of Stockholders

GlobeNewswire 5/6/2021 Adverum Reports First Quarter 2021 Results

GlobeNewswire 5/1/2021 Adverum Biotechnologies Presents Long-term Data through March 10, 2021 from the OPTIC Trial of ADVM-...

GlobeNewswire 4/28/2021 Adverum Biotechnologies Provides Update on the INFINITY Trial Evaluating ADVM-022 in Patients with D...